COMPOUNDING FINDER
Tirzepatide is a dual GIP/GLP-1 receptor agonist prescribed for type 2 diabetes and chronic weight management. Vermont patients with a documented clinical need may be eligible for compounded tirzepatide.
Vermont's small, rural population means local compounding options are limited. Compounding Finder helps Vermont residents connect with licensed pharmacies that ship throughout the state.
Yes. The Vermont Board of Pharmacy oversees compounding. A valid prescription with clinical justification is required.
Typically $150 to $450 per month.